find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
352
Clinical Trials
Bone Marrow Transplant
Phase I
Enrolling
nct/study# NCT05473910 / TSCAN-001
A Controlled Multi-Arm Ph1 Study Evaluating the Safety and Feasibility of TCR Engineered Donor TCells Targeting HA1 (TSC-100) or HA2 (TSC-101) in HLA-A0201 Positive Patients Undergoing Haploidentical Allogeneic Stem Cell Transplantation
Learn More
Bone Marrow Transplant
N/A
Enrolling
nct/study# N/A / SIND-31754-LIFILEUCEL
Single Patient Non-Emergency Use IND of Lifileucel (Amtagvi) for Patient EAA
Learn More
ES-SCLC
Phase III
Closed to Enrollment
nct/study# 5468489 / HLX-10-005-SCL301-E
A Randomized, Open-label Study of HLX10 plus Chemotherapy (Carboplatin- Etoposide) in comparison with Atezolizumab plus Chemotherapy in Previously Untreated US Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ASTRIDE)
Learn More
NSCLC
Phase III
Closed to Enrollment
nct/study# 5555732 / DS1062-A-U303
A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (Tropion-Lung07)
Learn More
MRD
Observational Study
Enrolling
Chronic Lymphocytic Leukemia
Phase II
Enrolling
nct/study# 4895436 / M20-356
A Multicenter, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Venetoclax-Obinutuzumab Retreatment in Patients with Recurring Chronic Lymphocytic Leukemia
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.